Hap Trading, LLC Alkermes Plc. Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $258,863 - $386,788	-12,057 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$23.37 - $32.13 $281,772 - $387,391	12,057 New	12,057 $372,000
Q2 2021 Aug 11, 2021	SELL	$18.78 - $25.15 $1.02 Million - $1.37 Million	-54,421 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$18.21 - $23.2 $991,006 - $1.26 Million	54,421 New	54,421 $1.02 Million

365

179M

145K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.25B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.